Quality by Design in Generic Drug Development: Modern Science-Based Approaches
Quality by Design (QbD) is now mandatory for generic drug development, transforming how manufacturers prove bioequivalence. It replaces end-product testing with science-based process control, cutting approval times and improving consistency. Learn how QbD works, its benefits, and real-world impacts.
History of Generic Drugs in the United States: How Cheaper Medicines Became the Norm
Generic drugs now make up over 90% of U.S. prescriptions but cost only 23% of total drug spending. Learn how the Hatch-Waxman Act and FDA regulations turned generics from rare exceptions into the backbone of affordable medicine.
Hatch-Waxman Act: How Federal Law Shapes Generic Drug Approval in the U.S.
The Hatch-Waxman Act created the legal framework for generic drug approval in the U.S., saving billions in healthcare costs. Learn how ANDAs, the Orange Book, and patent challenges make generics possible.